CD4 and cancer: In summary, the cancer tissue SN caused a partial reversion of the pathway activity profile towards that of resting CD4+ T cells in combination with a strong upregulation of the immune-suppressive TGFβ pathway and a decrease in the PI3K pathway activity, in line with the induction of an immunotolerant state.